Financial Freedom LLC’s AbbVie ABBV Stock Holding History

Financial Freedom LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.1K	Hold	111	–	–	0.01%	219
2025 Q4	$25.3K	Hold	111	–	–	0.01%	206
2025 Q3	$25.7K	Hold	111	–	–	0.01%	210
2025 Q2	$20.6K	Buy	111 +1	+0.9%	+$186	0.01%	225
2025 Q1	$23K	Buy	110 +1	+0.9%	+$194	0.01%	220
2024 Q4	$19.3K	Buy	109 +1	+0.9%	+$184	0.01%	227
2024 Q3	$21.3K	Buy	108 +1	+0.9%	+$187	0.01%	217
2024 Q2	$18.4K	Buy	107 +1	+0.9%	+$166	0.01%	228
2024 Q1	$19.3K	Buy	106 +1	+1%	+$172	0.01%	229
2023 Q4	$16.3K	Buy	105 +1	+1%	+$146	0.01%	239
2023 Q3	$15.5K	Buy	104 +1	+1%	+$147	0.01%	244
2023 Q2	$13.9K	Buy	103 +1	+1%	+$147	0.01%	244
2023 Q1	$16.2K	Sell	102 -6	-6%	-$917	0.01%	227
2022 Q4	$17.4K	Buy	+108	New	+$16.6K	0.01%	222

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Freedom LLC's ABBV Position: Q1 2026 in Review

Financial Freedom LLC held its AbbVie (ABBV) position steady in Q1 2026 at 111 shares worth $24.1K. The position accounts for 0.01% of the portfolio, ranked #219.

Financial Freedom LLC first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $25.7K in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Financial Freedom LLC held 111 shares of AbbVie worth $24.1K as of Q1 2026.
Financial Freedom LLC left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.01% of Financial Freedom LLC's portfolio in Q1 2026, its #219 holding.
Financial Freedom LLC first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Financial Freedom LLC's AbbVie position peaked at $25.7K in Q3 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.